2,3-Dihydro-5-(3-hydroxypropanoyl)-1H-pyrrolizine

Metabolite details

Identifier

DLLQYHQNPSDCSK-UHFFFAOYSA-N

InChI Key

DLLQYHQNPSDCSK-UHFFFAOYSA-N

IUPAC name

1-(6,7-dihydro-5H-pyrrolizin-3-yl)-3-hydroxypropan-1-one

Preferred name

2,3-Dihydro-5-(3-hydroxypropanoyl)-1H-pyrrolizine

INN name

—

Synonym

—

ChEBI

CHEBI:173504

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_ZYP_High_Dose